- Pagina principale
- Analisi delle app
- Teckro
- Teckro Vs. Shared Investigator Platform
Teckro vs. Shared Investigator Platform Utilizzo e statistiche
Teckro transforms your clinical trial protocol into a hub of communication and collaboration. It’s a digital platform that connects all study stakeholders with the knowledge they need, when they need it. Drugs from trials powered by Teckro have been granted priority review and approval by regulators in the US and Europe. Thousands of investigators and 20,000+ sites around the world rely on Teckro to execute clinical trials from biopharma sponsors, including 12 out of the Top 20 pharma companies. We support all therapeutic areas, all phases, and any trial model, whether traditional, virtual, or a hybrid approach - if Teckro isn't used on your clinical trial, ask your study manager for it.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
The Shared Investigator Platform (Cognizant SIP) Mobile App features a user friendly interface to navigate and manage your actions on the Shared Investigator Platform. With this app, site users can easily login using their existing SIP credentials and enable biometric authentication to simplify the subsequent login process. This app offers an easy review of the pending actions, accept study & pre-study invitations, Complete facility association tasks, view the study news, view study documents, complete Document Exchange tasks published by your sponsor organizations.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
TeckroRanking a confronto con Shared Investigator Platform
Confronta la tendenza di classifica Teckro nei ultimi 28 giorni rispetto a Shared Investigator Platform
Rank
Nessun dato disponibile
Classifica Teckro vs. Shared Investigator Platform per paese a confronto
Confronta la tendenza di classifica Teckro nei ultimi 28 giorni rispetto a Shared Investigator Platform
Nessun dato da visualizzare
Fai confronti con qualsiasi sito con la nostra prova gratuita
Teckro VS.
Shared Investigator Platform
26icembre d, 2024